# Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring

> **NCT04559191** · PHASE4 · UNKNOWN · sponsor: **National Cerebral and Cardiovascular Center, Japan** · enrollment: 90 (estimated)

## Conditions studied

- Coronary Atherosclerosis

## Interventions

- **DEVICE:** continuous glucose monitoring (CGM)

## Key facts

- **NCT ID:** NCT04559191
- **Lead sponsor:** National Cerebral and Cardiovascular Center, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559191, "Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04559191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*